EpilepsyGTx Funding: $43M Raised, Series A (2025)

EpilepsyGTx funding overview

EpilepsyGTx is based in London, United Kingdom. EpilepsyGTx has raised $43M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2025. The round record for EpilepsyGTx runs through 2025; nothing later has been disclosed. Investors on record include XGEN Venture, British Business Bank, UCL Technology Fund 2, Health Technology Holding, Undisclosed global biopharmaceutical company. 5 distinct backers are named across the disclosed rounds.

EpilepsyGTx at a glance

Total raised: $43M
Latest round: Series A
Latest round date: December 2025
Headquarters: London, United Kingdom
Notable investors: XGEN Venture, British Business Bank, UCL Technology Fund 2, Health Technology Holding, Undisclosed global biopharmaceutical company

Frequently asked about EpilepsyGTx funding

How much has EpilepsyGTx raised?: EpilepsyGTx has raised $43M in total disclosed funding across the rounds on record.
Who has invested in EpilepsyGTx?: XGEN Venture, British Business Bank, UCL Technology Fund 2, Health Technology Holding, Undisclosed global biopharmaceutical company are named among the investors backing EpilepsyGTx.
What was the latest EpilepsyGTx funding round?: The most recent disclosed round is a Series A, announced in December 2025.
Where is EpilepsyGTx based?: EpilepsyGTx is based in London, United Kingdom.
When did EpilepsyGTx last raise?: The last disclosed EpilepsyGTx round closed in December 2025 at Series A.

Round data for EpilepsyGTx is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in London and backer lists below.

EpilepsyGTx Funding: $43M Raised, Series A (2025)

EpilepsyGTx funding overview

EpilepsyGTx at a glance

Frequently asked about EpilepsyGTx funding

Companies related to EpilepsyGTx (20)

Browse related funding lists (6)